These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3502152)

  • 1. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
    Muratsugu M; Makino M; Kohda H; Sekiya C
    Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of circulating immune complex levels by ELISA using F(ab')2 anti-C3 antibody].
    Muratsugu M; Makino M
    Rinsho Byori; 1986 Oct; Spec No 69():53-9. PubMed ID: 3806992
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
    Casiglia D; Giardina E; Scarantino G; Triolo G
    Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU; Fumia S
    Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The measurement of circulating immune complexes using anti-C3 antibody micro ELISA].
    Hayashi S; Aochi H; Nagamine K; Oshida M; Kurata Y; Kawagoe H
    Rinsho Byori; 1986 Dec; 34(12):1408-12. PubMed ID: 3560472
    [No Abstract]   [Full Text] [Related]  

  • 10. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
    Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
    Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
    Olds LC; Miller JJ
    Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
    Davey MP; Korngold L
    Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A measurement of IgA-containing immune complexes by anti-C3 ELISA].
    Tanaka M
    Nihon Hifuka Gakkai Zasshi; 1986 Jul; 96(8):839-42. PubMed ID: 3784054
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.
    Yu JR; Lennette ET; Karpatkin S
    J Clin Invest; 1986 Jun; 77(6):1756-61. PubMed ID: 3011860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.